UVA Engineering's Kimberly Kelly, and her team at ZielBio Inc., have moved a potential cure for one of the world’s most heinous...
Science Serving Humanity
All too often, innovations in biomedical engineering that could significantly improve the healthcare of people around the world never enter the marketplace. The University of Virginia has joined forces with the Wallace H. Coulter Foundation in a groundbreaking effort to address the root causes of this bottleneck and commercialize promising treatments and techniques.
We are building out a new hands-on, high-touch ecosystem for translation even as we accelerate and broaden the flow of cutting-edge products, protocols and processes from University labs into clinical practice. Our goal is to realize Wallace Coulter’s goal of “science serving humanity.” We invite you to join us.
Hossack’s advancements have given health care providers life-saving information and the ability to treat patients with an elevated...
Springbok Analytics Raises $3M Seed Round for Their AI-Powered Platform that Converts MRIs into 3D Analysis of Muscles
A UVA Department of Biomedical Engineering-created company and partner of the NBA and NFL raised a $3 million seed round for their AI-...
UVA professor George Christ teams with UC Berkeley professor Kevin Edward Healy to develop a hydrogel material that can be placed...
More About Us
The mission of the UVA-Coulter Translational Partnership is to support research projects that are explicitly translational in nature and in the doing so, develop and validate models of translational that can be widely adopted.More
The insight and experience of our oversight committee is critical both to the success of the program and the progress of the individual projects we fund.More
Projects and Proposals
There are two paths to funding from the UVA-Coulter Partnership.More
$ 26 M
Coulter Program Endowment
$ 700 K
Invested in 6 - 8 projects per year
Projects funded over the last 12 years
$ 50 M
Follow-on funding from 17 Coulter-funded start-ups